Propranolol for the control of belligerent behavior following acute brain damage

Annals of Neurology
F A Elliott

Abstract

The belligerence of 7 patients who had suffered an acute brain insult was effectively controlled by propranolol in doses of 60 to 320 mg per day. Of the 7 patients, 3 were treated in the acute stage after a stroke, a severe closed head injury, and a gunshot wound of the brain, respectively. A chronic postconcussion syndrome associated with chronic irritability was present in 2, and 2 were not chronically irritable but suffered from intermittent attacks of explosive rage in response to minor irritations. In all instances the belligerent behavior was controlled without inducing general sedation.

References

Oct 1, 1976·Archives of Neurology·J D Easton, D G Sherman
Nov 6, 1975·The New England Journal of Medicine·R R YoungB T Shahani
May 1, 1966·The Journal of Pharmacy and Pharmacology·W MurmannM Saccani-Guelfi
Feb 1, 1968·Journal of Pharmaceutical Sciences·P N Yeoh, H H Wolf
Jul 1, 1971·Neuropharmacology·J G Bainbridge, D T Greenwood
Dec 14, 1974·British Medical Journal·N J YorkstonC W Havard

❮ Previous
Next ❯

Citations

Sep 1, 1988·Journal of Affective Disorders·J L RauschS C Risch
Jan 1, 2003·Neuropsychological Rehabilitation·Peter Eames Eames, Rodger Ll Wood
Oct 6, 2006·Journal of Neurotrauma·UNKNOWN Neurobehavioral Guidelines Working GroupGeorge Zitnay
Mar 1, 1990·Journal of the American Academy of Child and Adolescent Psychiatry·J T StewartW B Lyles
Mar 7, 2003·Cardiology in Review·Seth Keller, William H Frishman
Dec 1, 1979·Archiv für Psychiatrie und Nervenkrankheiten·H J MöllerE Riedel
Apr 1, 1988·Brain Injury : [BI]·A M Levine
Feb 18, 2014·The Psychiatric Clinics of North America·David B Arciniegas, Hal S Wortzel
Mar 1, 1987·Mayo Clinic Proceedings·S C Jenkins, T Maruta
Oct 13, 2009·Clinics in Sports Medicine·Todd LefkowitzGerard Varlotta
Sep 1, 1992·Comprehensive Psychiatry·T W McAllister
Feb 1, 1996·Archives of Physical Medicine and Rehabilitation·J F Malec, J S Basford
May 1, 1986·Journal of the American Geriatrics Society·S C Risse, R Barnes
Jan 1, 1993·Neuroscience and Biobehavioral Reviews·D J AlbertR H Jonik
Oct 1, 1988·Journal of Geriatric Psychiatry and Neurology·P G WeilerC Bernick
Dec 27, 2011·Journal of Clinical Psychopharmacology·Stefano ComaiGabriella Gobbi
Nov 5, 2011·Journal of Clinical Psychopharmacology·William J Newman, Barbara E McDermott
Jan 1, 1981·Medicinal Research Reviews·L Patel, P Turner
May 1, 1979·The British Journal of Psychiatry : the Journal of Mental Science·G P Sheppard
Nov 1, 1988·Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie·N Grizenko, S Vida
Feb 1, 1990·Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie·G Abraham, F Jarrett
Oct 21, 2006·The Cochrane Database of Systematic Reviews·S FlemingerD L Oliver

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.